Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.63 |
| ▸ | NPC1 | O15118 | 6/20 | 0.59 |
| ▸ | RAB9A | P51151 | 6/20 | 0.59 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.56 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.56 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.56 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.55 |
| ▸ | F10 | P00742 | 1/20 | 0.55 |
| ▸ | PLG | P00747 | 1/20 | 0.55 |
| ▸ | PLAU | P00749 | 1/20 | 0.55 |
| ▸ | PLAT | P00750 | 1/20 | 0.55 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.55 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4804024 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL12450700 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL7298450 | 0.81 | SMN1; SMN2 (0.63) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL12914553 | 0.81 | SMN1; SMN2 (0.68) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL7298453 | 0.81 | SMN1; SMN2 (0.63) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL24524106 | 0.81 | SMN1; SMN2 (0.63) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL14422342 | 0.81 | SMN1; SMN2 (0.63) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL14000532 | 0.81 | SMN1; SMN2 (0.63) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL21217197 | 0.81 | SMN1; SMN2 (0.68) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B | |
| SCHEMBL11974092 | 0.80 | PLCG2 (0.78) | SMN1; SMN2NPC1RAB9ACSNK2A2CSNK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7455960-B2 | Photothermographic material | FUJIFILM CORPORATION (JP) | 2008-11-25 | — | — | US | disclosed |
| US-7455960-B2 | Photothermographic material | FUJIFILM CORPORATION (JP) | 2008-11-25 | — | — | US | disclosed |
| US-7448533-B2 | Medical image file management system and medical image film | FUJIFILM CORPORATION (JP) | 2008-11-11 | — | — | US | disclosed |
| US-7448533-B2 | Medical image file management system and medical image film | FUJIFILM CORPORATION (JP) | 2008-11-11 | — | — | US | disclosed |
| US-7429447-B2 | Photothermographic material and image forming method | FUJIFILM CORPORATION (JP) | 2008-09-30 | — | — | US | disclosed |
| US-7429447-B2 | Photothermographic material and image forming method | FUJIFILM CORPORATION (JP) | 2008-09-30 | — | — | US | disclosed |
| US-20080188667-A1 | AZLACTONE COMPOUND AND METHOD FOR PREPARATION THEREOF | AJINOMOTO CO., INC (JP) | 2008-08-07 | — | — | US | disclosed |
| WO-2008076218-A1 | PHOTOTHERMOGRAPHIC MATERIALS CONTAINING DEVELOPER AND CO-DEVELOPER | CARESTREAM HEALTH, INC. (US) | 2008-06-26 | — | — | WO | disclosed |
| US-20080145801-A1 | PHOTOTHERMOGRAPHIC MATERIALS CONTAINING DEVELOPER AND CO-DEVELOPER | CARESTREAM HEALTH, INC. | 2008-06-19 | — | — | US | disclosed |
| US-20080145801-A1 | PHOTOTHERMOGRAPHIC MATERIALS CONTAINING DEVELOPER AND CO-DEVELOPER | CARESTREAM HEALTH, INC. | 2008-06-19 | — | — | US | disclosed |
| US-7166408-B2 | Image forming method using photothermographic material | FUJIFILM CORPORATION (JP) | 2007-01-23 | — | — | US | disclosed |
| US-7166408-B2 | Image forming method using photothermographic material | FUJIFILM CORPORATION (JP) | 2007-01-23 | — | — | US | disclosed |
| US-20070003884-A1 | Photothermographic material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20070003884-A1 | Photothermographic material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| US-7157665-B2 | Heat development apparatus and method | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-7157665-B2 | Heat development apparatus and method | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-7158164-B2 | Thermal development method and apparatus | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-7158164-B2 | Thermal development method and apparatus | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| US-20050137404-A1 | Azlactone compound and method for preparation thereof | AJINOMOTO CO. INC (JP) | 2005-06-23 | — | — | US | disclosed |
| EP-1533306-A1 | Azlactone compound and method for preparation thereof | Ajinomoto Co., Inc. (JP) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137404-A1 | Azlactone compound and method for preparation thereof | KCNH2, KCNH3, WNK2 | SMN1; SMN2 3930/4885NPC1 2819/4885RAB9A 434/4885 |
| US-20080188667-A1 | AZLACTONE COMPOUND AND METHOD FOR PREPARATION THEREOF | KCNH2, KCNH3, WNK2 | SMN1; SMN2 3930/4885NPC1 2819/4885RAB9A 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.